These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16312627)

  • 1. Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
    Sanduzzi A; Nani E; Giacomelli P; Amato G; Bariffi F
    J Chemother; 1989 Jul; 1(4 Suppl):762-3. PubMed ID: 16312627
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
    Fassas A; Papageorgiou T; Kontodimou A; Proya E; Hadjikyrkou M; Anagnostopoulos A
    J Chemother; 1989 Jul; 1(4 Suppl):1295-7. PubMed ID: 16312872
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues].
    Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV
    Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical study of imipenem/cilastatin in the treatment of generalized and localized infections.
    Tigano F; D'Ambrosio FP; Angio LG
    J Chemother; 1989 Jul; 1(4 Suppl):638-40. PubMed ID: 16312569
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intra-abdominal infections using imipenem/cilastatin.
    Leaper D; Thomas W; Kennedy R; Leow C; Avery D
    Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections.
    Goldoni S; Gandolfi P; Tubaro A; Vicentini C; Lancione P; Miano L
    J Chemother; 1989 Jul; 1(4 Suppl):845-7. PubMed ID: 16312665
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of imipenemcilastatin in the therapy of severe infections in high risk patients.
    Cristiano P; Iovene MR; Morelli G; Simioli F; Lobello R; Altucci P
    J Chemother; 1989 Jul; 1(4 Suppl):643-4. PubMed ID: 16312571
    [No Abstract]   [Full Text] [Related]  

  • 11. Imipenem + cilastatin--a new type of antibiotic.
    Drug Ther Bull; 1991 May; 29(11):43-4. PubMed ID: 1935582
    [No Abstract]   [Full Text] [Related]  

  • 12. Puerperal infections: experiences with imipenem/cilastatin.
    Heilmann L; Hoynacki B
    J Chemother; 1989 Jul; 1(4 Suppl):877-8. PubMed ID: 16312682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Imipenem-cilastatin in nosocomial infections in HIV+ patients].
    Pagano G; Repetto T; Ferrazin A; Canessa A; Carrega G
    G Ital Chemioter; 1991; 38(1-3):191-2. PubMed ID: 1365589
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin].
    Fiorentino F; De Sena R; Manzillo E; Iadanza A; Conte M; Coppola MG; Galderisi P; Postiglione A; Arciello MT; Covelli B
    Clin Ter; 1989 May; 129(4):287-91. PubMed ID: 2527122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of imipenem-cilastatin in acute ORL infections].
    Cerqua N; Tirelli GC; Piccirillo E
    Riv Eur Sci Med Farmacol; 1992; 14(6):409-10. PubMed ID: 1308610
    [No Abstract]   [Full Text] [Related]  

  • 16. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem/cilastatin in a group of obstetrics/gynecological surgical patients.
    Martinelli P; Votino F; Nicotra A; Buoninfante L; Sorrentino P; Montemagno U
    J Chemother; 1989 Jul; 1(4 Suppl):875-6. PubMed ID: 16312681
    [No Abstract]   [Full Text] [Related]  

  • 18. Imipenem-cilastatin sodium.
    Stene R
    Iowa Med; 1986 Sep; 76(9):432-7. PubMed ID: 3771166
    [No Abstract]   [Full Text] [Related]  

  • 19. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients.
    Benoni G; Cuzzolin L; Bertrand C; Pucchetti V; Velo G
    Chemioterapia; 1987 Jun; 6(2 Suppl):259-60. PubMed ID: 3509404
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbapenems.
    Schlossberg D; Pietroski N
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):4. PubMed ID: 12118842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.